Www.aodhealth.org 1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2010.

Slides:



Advertisements
Similar presentations
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
Advertisements

Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2013.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July-August 2007.
Journal Club Alcohol and Health: Current Evidence March-April 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2009.
Journal Club Alcohol and Health: Current Evidence November–December 2004.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Journal Club Alcohol and Health: Current Evidence May–June 2005.
Journal Club Alcohol and Health: Current Evidence March-April 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence April 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2011.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2009.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2011.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September-October 2007.
Journal Club Alcohol and Health: Current Evidence November-December 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2010.
Journal Club Alcohol and Health: Current Evidence May-June 2006.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Journal Club Alcohol and Health: Current Evidence January-February 2005.
Journal Club Alcohol and Health: Current Evidence September-October 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
Journal Club Alcohol and Health: Current Evidence January–February 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2009.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2012.
Journal Club Meena Meka MD. Topic Association of Coffee Drinking with Total and Cause-Specific Mortality.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
Prognostic Utility of Secretory Phospholipase A 2 in Patients with Stable Coronary Artery Disease M. O'Donoghue, Z. Mallat, D.A. Morrow, J. Benessiano,
Complete Recovery of Renal Function After Acute Kidney Injury is Associated with Long-Term All-Cause Mortality In a Large Managed Care Organization Jennifer.
Coffee Consumption and Risk of Myocardial Infarction among Older Swedish Women SA Rosner, A Akesson,MJ. Stampfer, A Wolk; AJE; :
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2012.
ALCOHOL AND HEALTH Morten Grønbæk National Institute of Public Health Copenhagen, Denmark.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2012.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2012.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2014.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2015.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2012.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2013.
Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.
Loss of anterior forces (R waves) may signify prior anterior myocardial infarction. The aim of the present study was to determine the prevalence and prognostic.
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Alcohol, Other Drugs, and Health: Current Evidence
Alcohol, Other Drugs, and Health: Current Evidence
Alcohol, Other Drugs, and Health: Current Evidence March–April 2017
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Baseline characteristics of patients
Alcohol, Other Drugs, and Health: Current Evidence March–April 2018
Alcohol, Other Drugs, and Health: Current Evidence
Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.
Alcohol, Other Drugs, and Health: Current Evidence July-August, 2018
Alcohol, Other Drugs, and Health: Current Evidence
Subgroup analysis of associations between egg consumption and risk of incident cardiovascular disease (CVD), ischaemic heart disease (IHD), haemorrhagic.
Alcohol, Other Drugs, and Health: Current Evidence May–June 2019
Presentation transcript:

1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2010

2 Featured Article Patterns of Alcohol Consumption and Ischaemic Heart Disease in Culturally Divergent Countries The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Ruidavets JB, et al. BMJ. 2010:23;341:c6077.

3 Study Objective To investigate the effect of alcohol intake patterns on ischemic heart disease in 2 countries with contrasting lifestyles (Northern Ireland and France).

4 Study Design Analysis of cohort data from the Prospective Epidemiological Study of Myocardial Infarction (PRIME) from 1 center in Belfast and 3 centers in France. The sample included 9778 men aged 50–59 and free of ischemic heart disease at baseline. Participants were assessed at baseline for: –weekly alcohol consumption– frequency of consumption –incidence of binge drinking*– type of beverage consumed –incidence of regular drinking† *Consumption of >50 g alcohol at least 1 day per week. †Consumption at least 1 day a week, alcohol <50 g if on only 1 occasion.

5 Study Design (cont’d) The relationship between baseline characteristics, coronary events (myocardial infarction [MI] and coronary death), and angina events over 10-year follow-up was assessed using Cox’s proportional hazards regression analysis.

6 Assessing Validity of an Article About Harm Are the results valid? What are the results? How can I apply the results to patient care?

7 Are the Results Valid? Did the investigators demonstrate similarity in all known determinants of outcomes? Did they adjust for differences in the analysis? Were exposed patients equally likely to be identified in the two groups? Were the outcomes measured in the same way in the groups being compared? Was follow-up sufficiently complete?

8 Did the investigators demonstrate similarity in all known determinants of outcomes? Did they adjust for differences in the analysis? The sample included men only, similar in age and with no baseline history of ischemic heart disease. Analyses were adjusted for the following factors known to be predictive of ischemic heart disease: − age − education − waist circumference − systolic blood pressure − diabetes, dyslipidemia, or hypertension − physical activity − tobacco consumption, pack years − apolipoprotein A-1 concentration − apolipoprotein B concentration

9 Were exposed patients equally likely to be identified in the groups?  Although this study addressed drinking pattern, self-reported alcohol consumption on a typical week in the year prior to baseline examination was the exposure.  Follow-up did not assess for changes in consumption over time.

10 Were the outcomes measured in the same way in the groups being compared?  Extensive clinical information was gathered for any patient who reported a possible clinical event over the 10-year follow-up period: −hospital and physician notes; hospital admissions; electrocardiograms; MI biomarkers; surgical procedures; angioplasty; myocardial perfusion scintigraphy; echocardiography; postmortem information on participants who died.  A committee comprised of 1 PRIME researcher, 1 member of the PRIME coordinating center, and 3 independent cardiologists reviewed all collected medical data.

11 Was follow-up sufficiently complete? Of the overall sample (N=9778), –317 men (3%) were lost to follow-up. –215 (2%) refused continued participation. –653 (6.1%) died.

12 What are the Results? How strong is the association between exposure and outcomes? How precise is the estimate of the risk?

13 How strong is the association between exposure and outcome? How precise is the estimate of the risk? –The hazard ratio (HR) for coronary events in binge drinkers * compared with regular drinkers † was 1.81 (95% CI, 1.05– 3.11) in Belfast and 1.93 (95% CI, 0.46–7.40) in France. –Combining all sites, the HR for coronary events compared with regular drinkers was 2.03 (95% CI, 1.41–2.94) in never drinkers and 1.97 (95% CI, 1.21–3.22) in binge drinkers. The HR for former drinkers compared with regular drinkers was 1.57 (95% CI, 1.11–2.21). –Alcohol intake was not associated with incidence of anginal events. *Consuming ≥50 g alcohol at least 1 day per week. †Consuming <50 g alcohol at least 1 day per week.

14 How Can I Apply the Results to Patient Care? Were the study patients similar to the patients in my practice? Was the duration of follow-up adequate? What was the magnitude of the risk? Should I attempt to stop the exposure?

15 Were the study patients similar to the patients in my practice? Subjects were Irish and French men aged 50–59 at baseline. Further race/ethnicity data were not provided.

16 Was the duration of follow-up adequate? Yes. Follow-up was at 10 years.

17 What was the magnitude of the risk? Compared with regular drinkers, the HR for coronary events was 2.03 in never drinkers and 1.97 in binge drinkers. The HR for former drinkers compared with regular drinkers was 1.57.

18 Should I attempt to stop the exposure? The results suggest a cardiovascular benefit with consumption of <50 g alcohol at least 1 day per week.